GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Propanc Biopharma, Inc. (PPCB) | 8/21/2026 6:02:16 AM | View | Proxy | SEC | |||||||
| Propanc Biopharma, Inc. (PPCB) | 5/15/2026 8:47:03 AM | View | Financials | Earnings | WIRE | 3Q 2026 | Assets $14,333,780 | EPS -$0.28 | Export Earnings Model | ||
| Propanc Biopharma, Inc. (PPCB) | 5/14/2026 5:44:51 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2026 ending: 3/31/2026 | Assets $14,333,780 | EPS -$0.28 | ||
| Propanc Biopharma, Inc. (PPCB) | 3/31/2026 6:17:11 AM | View | Proxy | SEC | Y 2025 | ||||||
| Propanc Biopharma, Inc. (PPCB) | 2/18/2026 8:45:44 AM | View | Financials | Earnings | WIRE | 2Q 2026 | Assets $15,111,532 | EPS -$0.30 | Export Earnings Model | ||
| Propanc Biopharma, Inc. (PPCB) | 2/17/2026 3:04:08 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 12/31/2025 | Assets $15,111,532 | EPS -$0.30 | ||
| Propanc Biopharma, Inc. (PPCB) | 12/29/2025 5:14:19 PM | View | Proxy | SEC | Y 2025 | ||||||
| Propanc Biopharma, Inc. (PPCB) | 11/14/2025 12:14:31 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 9/30/2025 | Assets $17,975,681 | EPS -$0.39 | ||
| Propanc Biopharma, Inc. (PPCB) | 9/29/2025 5:43:51 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 6/30/2025 | Assets $19,631,808 | EPS -$14.85 | ||
| Propanc Biopharma, Inc. (PPCB) | 5/15/2025 3:53:11 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 3/31/2025 | Assets $22,527,352 | EPS -$12.50 | ||
| Propanc Biopharma, Inc. (PPCB) | 2/14/2025 1:36:03 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 12/31/2024 | Assets $78,533 | EPS -$32.23 | ||
| Propanc Biopharma, Inc. (PPCB) | 11/14/2024 2:23:40 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 9/30/2024 | Assets $63,644 | |||
| Propanc Biopharma, Inc. (PPCB) | 9/30/2024 5:00:18 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 6/30/2024 | Assets $72,365 | EPS -$0.02 | ||
| Propanc Biopharma, Inc. (PPCB) | 8/22/2024 7:09:19 AM | View | Proxy | SEC | Y 2024 | ||||||
| Propanc Biopharma, Inc. (PPCB) | 5/15/2024 4:58:49 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 3/31/2024 | Assets $37,337 | EPS -$0.01 | ||
| Propanc Biopharma, Inc. (PPCB) | 2/20/2024 2:55:24 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 12/31/2023 | Assets $241,907 | EPS -$0.03 | ||
| Propanc Biopharma, Inc. (PPCB) | 11/14/2023 3:29:17 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 9/30/2023 | Assets $180,371 | EPS -$0.04 | ||
| Propanc Biopharma, Inc. (PPCB) | 9/28/2023 4:26:52 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 6/30/2023 | Assets $60,328 | EPS -$1.80 | ||
| Propanc Biopharma, Inc. (PPCB) | 5/15/2023 4:24:19 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 3/31/2023 | Assets $143,742 | |||
| Propanc Biopharma, Inc. (PPCB) | 2/10/2023 6:18:54 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 12/31/2022 | Assets $108,022 | |||
| Propanc Biopharma, Inc. (PPCB) | 11/14/2022 4:48:39 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 9/30/2022 | Assets $94,254 | |||
| Propanc Biopharma, Inc. (PPCB) | 10/5/2022 6:05:18 AM | View | Proxy | SEC | Y 2022 | ||||||
| Propanc Biopharma, Inc. (PPCB) | 9/28/2022 4:30:03 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 6/30/2022 | Assets $81,651 | |||
| Propanc Biopharma, Inc. (PPCB) | 6/9/2022 12:36:28 PM | View | Proxy | SEC | Y 2021 | ||||||
| Propanc Biopharma, Inc. (PPCB) | 5/16/2022 11:37:56 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 3/31/2022 | Assets $169,460 | |||
| Propanc Biopharma, Inc. (PPCB) | 2/14/2022 1:24:06 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 12/31/2021 | Assets $110,177 | |||
| Propanc Biopharma, Inc. (PPCB) | 11/12/2021 5:02:47 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 9/30/2021 | Assets $62,165 | |||
| Propanc Biopharma, Inc. (PPCB) | 9/28/2021 4:02:08 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 6/30/2021 | Assets $13,101 | |||
| Propanc Biopharma, Inc. (PPCB) | 5/14/2021 5:34:55 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 3/31/2021 | Assets $28,043 | |||
| Propanc Biopharma, Inc. (PPCB) | 2/12/2021 3:22:51 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 12/31/2020 | Assets $40,616 | EPS -$0.45 | ||
| Propanc Biopharma, Inc. (PPCB) | 11/16/2020 12:11:55 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 9/30/2020 | Assets $77,554 | EPS -$0.71 | ||
| Propanc Biopharma, Inc. (PPCB) | 10/1/2020 5:45:18 PM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 6/30/2020 | Assets $98,518 | EPS -$192.45 | ||
| Propanc Biopharma, Inc. (PPCB) | 8/5/2020 5:14:38 PM | View | Proxy | SEC | Y 2020 | ||||||
| Propanc Biopharma, Inc. (PPCB) | 5/15/2020 4:56:08 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 3/31/2020 | Assets $63,938 | EPS -$348.75 | ||
| Propanc Biopharma, Inc. (PPCB) | 2/19/2020 6:02:35 AM | View | Proxy | SEC | Y 2019 | ||||||
| Propanc Biopharma, Inc. (PPCB) | 2/14/2020 5:42:54 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 12/31/2019 | Assets $65,425 | EPS -$1,250.78 | ||
| Propanc Biopharma, Inc. (PPCB) | 11/14/2019 5:47:26 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 9/30/2019 | Assets $197,663 | EPS -$1.41 | ||
| Propanc Biopharma, Inc. (PPCB) | 10/15/2019 5:55:20 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 6/30/2019 | Assets $101,652 | EPS -$10.97 | ||
| Propanc Biopharma, Inc. (PPCB) | 5/15/2019 5:30:54 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 3/31/2019 | Assets $259,916 | EPS -$0.89 | ||
| Propanc Biopharma, Inc. (PPCB) | 3/18/2019 8:02:37 AM | View | Proxy | SEC | Y 2018 | ||||||
| Propanc Biopharma, Inc. (PPCB) | 2/14/2019 6:25:10 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 12/31/2018 | Assets $712,597 | EPS -$41.33 | ||
| Propanc Biopharma, Inc. (PPCB) | 11/13/2018 6:07:57 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 9/30/2018 | Assets $82,775 | EPS -$10.00 | ||
| Propanc Biopharma, Inc. (PPCB) | 9/17/2018 6:08:02 PM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 6/30/2018 | Assets $71,387 | EPS -$178.75 | ||
| Propanc Biopharma, Inc. (PPCB) | 8/28/2018 5:20:28 PM | View | Proxy | SEC | Y 2018 | ||||||
| Propanc Biopharma, Inc. (PPCB) | 5/10/2018 5:45:44 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 3/31/2018 | Assets $110,746 | EPS -$0.06 | ||
| Propanc Biopharma, Inc. (PPCB) | 2/9/2018 6:22:52 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 12/31/2017 | Assets $129,081 | EPS -$0.20 | ||
| Propanc Biopharma, Inc. (PPCB) | 12/29/2017 10:51:12 AM | View | Proxy | SEC | Y 2017 | ||||||
| Propanc Biopharma, Inc. (PPCB) | 11/9/2017 5:13:42 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 9/30/2017 | Assets $162,512 | EPS -$0.36 | ||
| Propanc Biopharma, Inc. (PPCB) | 9/28/2017 4:45:43 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 6/30/2017 | Assets $95,069 | EPS -$2.24 | ||
| Propanc Biopharma, Inc. (PPCB) | 5/8/2017 5:42:36 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 3/31/2017 | Assets $44,786 | EPS -$0.38 | ||
| Propanc Health Group Corp (PPCB) | 3/13/2017 5:06:35 PM | View | Proxy | SEC | Y 2016 | ||||||
| Propanc Health Group Corp (PPCB) | 2/14/2017 12:58:01 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 12/31/2016 | Assets $135,838 | EPS -$1.13 | ||
| Propanc Health Group Corp (PPCB) | 11/10/2016 5:29:45 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 9/30/2016 | Assets $181,395 | EPS -$0.36 | ||
| Propanc Health Group Corp (PPCB) | 9/28/2016 5:24:51 PM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 6/30/2016 | Assets $379,142 | EPS -$4.83 | ||
| Propanc Health Group Corp (PPCB) | 5/16/2016 1:54:17 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 3/31/2016 | Assets $1,623,115 | EPS -$1.05 | ||
| Propanc Health Group Corp (PPCB) | 2/16/2016 1:09:06 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 12/31/2015 | Assets $1,507,988 | EPS -$0.01 | ||
| Propanc Health Group Corp (PPCB) | 11/16/2015 3:10:19 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 9/30/2015 | Assets $305,121 | |||
| Propanc Health Group Corp (PPCB) | 9/30/2015 5:13:03 PM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 6/30/2015 | Assets $627,068 | EPS -$0.02 | ||
| Propanc Health Group Corp (PPCB) | 5/15/2015 3:48:31 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2015 ending: 3/31/2015 | Assets $309,624 | |||
| Propanc Health Group Corp (PPCB) | 2/17/2015 9:56:00 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2015 ending: 12/31/2014 | Assets $52,940 | |||
| Propanc Health Group Corp (PPCB) | 12/18/2014 3:59:38 PM | View | Proxy | SEC | Y 2014 | ||||||
| Propanc Health Group Corp (PPCB) | 11/19/2014 5:18:29 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2015 ending: 9/30/2014 | Assets $51,572 | EPS -$0.01 | ||
| Propanc Health Group Corp (PPCB) | 10/14/2014 4:28:15 PM | Micro | View | Financials | 10-K | SEC | Y 2014 ending: 6/30/2014 | Assets $113,745 | EPS -$0.01 | ||
| Propanc Health Group Corp (PPCB) | 5/20/2014 9:02:56 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2014 ending: 3/31/2014 | Assets $40 | |||
| Propanc Health Group Corp (PPCB) | 2/14/2014 11:34:23 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2014 ending: 12/31/2013 | Assets $11,923 | |||
| Propanc Health Group Corp (PPCB) | 11/14/2013 3:04:48 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2014 ending: 9/30/2013 | Assets $38,717 | EPS -$0.01 | ||
| Propanc Health Group Corp (PPCB) | 10/15/2013 3:19:50 PM | Micro | View | Financials | 10-K | SEC | Y 2013 ending: 6/30/2013 | Assets $1,747 | EPS -$0.02 | ||
| Propanc Health Group Corp (PPCB) | 5/20/2013 2:22:17 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2013 ending: 3/31/2013 | Assets $4,138 | |||
| Propanc Health Group Corp (PPCB) | 2/20/2013 5:30:00 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2013 ending: 12/31/2012 | Assets $12,300 | EPS -$0.02 | ||
| Propanc Health Group Corp (PPCB) | 11/19/2012 4:14:22 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2013 ending: 9/30/2012 | Assets $27,086 | EPS -$0.01 | ||
| Propanc Health Group Corp (PPCB) | 10/15/2012 3:12:18 PM | Micro | View | Financials | 10-K | SEC | Y 2012 ending: 6/30/2012 | Assets $46,268 | EPS -$0.16 | ||
| Propanc Health Group Corp (PPCB) | 5/21/2012 11:43:53 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2012 ending: 3/31/2012 | Assets $2,158,692 | EPS -$0.04 | ||
| Propanc Health Group Corp (PPCB) | 3/7/2012 5:28:54 PM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2012 ending: 12/31/2011 | Assets $4,872,856 | EPS -$0.03 |